Additional file 1 of Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study

Additional file 1: Supplementary Table 1. Inclusion criteria. Supplementary Table 2. Exclusion criteria. Supplementary Table 3. EGFR mutations found in pre-treatment biopsies. Supplementary Table 4. Results of †EGFR testing among 18 patients who reached ‡PD. Supplementary Table 5. †EGFR mutation found by liquid biopsy at intermediate. Supplementary Table 6. Safety summary in patients treated with afatinib. Supplementary Table 7. All-cause adverse events

Additional file 6 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

Additional file 6. Admission to intensive care unitand use of invasive mechanical ventilationof bacterial respiratory infection with coronavirus disease 2019

Additional file 1 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

Additional file 1. Identification of organisms in ventilator-associated pneumoniacase

Additional file 4 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

Additional file 4. Details of respiratory secondary infection

Additional file 5 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

Additional file 5. Association of anti-IL-6 receptor antibody use with incidence of secondary infection and death

Additional file 8 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

Additional file 8. Proportion of thrombosis and myocardial injury in bacterial respiratory co-infection and secondary infection with coronavirus disease 2019

Additional file 3 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

Additional file 3. Neutrophil-lymphocyte ratioas a predictor of co-infection in steroid and non-steroid user

Additional file 2 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

Additional file 2. Evaluation of white blood cells, neutrophils, lymphocytes, neutrophil-lymphocyte ratio, C-reactive protein, and procalcitonin on admission as predictors of respiratory bacterial co-infection based on the area under the curv

Additional file 7 of Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

Additional file 7. Forest plot of adjusted oddsratios by multivariate logistic regression analysis of risk factors of death in patients of coronavirus disease 2019with secondary infection except ventilator-associated pneumoniaand VAP